Doximity (DOCS) Company Overview

The earnings call transcript for Doximity, Inc. (DOCS) for the third quarter of 2025 is available.

Doximity (DOCS) reported quarterly earnings of $0.45 per share, which is higher than the Zacks Consensus Estimate of $0.33 per share. This is an increase compared to earnings of $0.29 per share from the same period last year.

Doximity announced its financial results for the third quarter of fiscal 2025, surpassing what analysts had predicted for both revenue and future guidance. The company's revenue rose by 25%, reaching $168.6 million in this quarter.

Doximity (DOCS 0.21%), a digital platform for healthcare professionals in the U.S., announced its financial results for the third quarter on February 6, 2025. The company achieved strong performance, exceeding the expectations of analysts as well as its own predictions.

This Analyst Blog features Doximity, Omnicell, Embecta, Cencora, and EDOC.

Doximity (DOCS) finished the last trading day at $58.18, which is an increase of 0.61% compared to the day before.

Doximity's stock rose more than 34% after its latest earnings report on November 11. Currently, the shares are approaching a point where they could be a good buy.

This Analyst Blog features McKesson, Doximity, and Veracyte.

Doximity is a leader in digital healthcare, with more than 80% of doctors in the U.S. using its platform, which strengthens its competitive edge. The company has strong financial performance, exceeding earnings expectations, maintaining good cash reserves, and achieving high profit margins, showing it can grow and operate efficiently. New AI features and product launches improve clinical processes, and the leadership's successful history suggests ongoing growth and expansion of services.